calendar
7,854 catalysts · 4,970 phase readout · 2,318 8k filing · 283 earnings · 277 pdufa · 115 phase 2 completion · 53 phase 1 completion
next 91 dayslessmore
MonWedFri
7,854 catalysts · 4,970 phase readout · 2,318 8k filing · 283 earnings · 277 pdufa · 115 phase 2 completion · 53 phase 1 completion
Sponsor: Institutt for Psykologisk Radgivning. Phase: NA. Conditions: Depression
Sponsor: Ultra Botanica LLC. Phase: NA. Conditions: Joint Discomfort, Quality of Life (QOL)
Sponsor: Kristina Simonyan. Phase: PHASE1. Conditions: Spasmodic Dysphonia, Laryngeal Dystonia, Voice Tremor
Sponsor: Pfizer. Phase: PHASE2. Conditions: Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
Sponsor: Medical College of Wisconsin. Phase: NA. Conditions: Neonatal Respiratory Distress Related Conditions, Meconium, Perinatal Morbidity, Neonatal Acidosis, Cord Blood, Neonatal Brain Injury, Maternal Morbidity, Mechanical Ventilation, CPAP, Surfactant, Perinatal Death, Amnioinfusion, NICU Admission
Sponsor: Assiut University. Phase: . Conditions: Haematological Disorders
Sponsor: Institute of Liver and Biliary Sciences, India. Phase: NA. Conditions: Liver Cirrhosis
Sponsor: Celgene. Phase: PHASE1. Conditions: Multiple Myeloma
Sponsor: XVIVO Perfusion. Phase: NA. Conditions: Heart Transplant, Heart Failure, Transplant; Failure, Heart
Sponsor: George F. Hatch. Phase: PHASE4. Conditions: Ligament Tear Knee
Sponsor: University Hospital Ostrava. Phase: NA. Conditions: Prolonged Mechanical Ventilation, Critical Illness
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS). Phase: . Conditions: Neurologic Disorders
Sponsor: University of Vermont. Phase: NA. Conditions: Prostate Cancer
Sponsor: Washington University School of Medicine. Phase: PHASE2. Conditions: Pancreas Cancer, Cancer of the Pancreas, Pancreas Adenocarcinoma
Sponsor: Joslin Diabetes Center. Phase: NA. Conditions: Childhood Obesity Prevention, Childhood Obesity, Physical Activity, Lactation, Breastfeeding, Pregnancy, Exercise
Sponsor: Beijing Tongren Hospital. Phase: PHASE1. Conditions: Extranodal NK T Cell Lymphoma, Hemophagocytic Lymphohistiocytosis (HLH)
Sponsor: Sanford Health. Phase: NA. Conditions: Parkinsons Disease (PD)
Sponsor: Cogent Biosciences, Inc.. Phase: . Conditions: Systemic Mastocytoses, Indolent, Systemic Mastocytoses, Aggressive
Sponsor: Assiut University. Phase: NA. Conditions: Early Onset Scoliosis (EOS)
Sponsor: ECOG-ACRIN Cancer Research Group. Phase: PHASE2. Conditions: Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8
Sponsor: Hospital dos Lusíadas. Phase: NA. Conditions: Morbid Obesity, Postoperative Pain, Opioid Free Anesthesia, Bariatric Surgery
Sponsor: Biosense Webster, Inc.. Phase: NA. Conditions: Scar-related Atrial Tachycardia, Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation, Ventricular Procedures, Ventricular Tachycardia, Ischemic Ventricular Tachycardia, Non-ischemic Ventricular Tachycardia, Cardiomyopathy, Idiopathic Ventricular Tachycardia, Premature Ventricular Contraction
Sponsor: Dana-Farber Cancer Institute. Phase: . Conditions: HPV Infection, HPV Positive Oropharyngeal Squamous Cell Carcinoma
Sponsor: Shanghai Jiao Tong University School of Medicine. Phase: EARLY_PHASE1. Conditions: Autism Spectrum Disorder
Sponsor: Rigshospitalet, Denmark. Phase: NA. Conditions: Cardiac Amyloidosis, Chest Pain
Sponsor: Dana-Farber Cancer Institute. Phase: PHASE1. Conditions: Chronic Lymphocytic Leukemia
Sponsor: Sheikh Zayed Medical College. Phase: NA. Conditions: Episiotomy Extended by Laceration
Sponsor: BioVie Inc.. Phase: PHASE2. Conditions: Parkinsons Disease (PD)
Sponsor: Meyer Children's Hospital IRCCS. Phase: NA. Conditions: COL4A1\2, COL4A1-Related Brain Small Vessel Disease With Haemorrhage
Sponsor: LaNova Medicines Zhejiang Co., Ltd.. Phase: PHASE3. Conditions: Locally Advanced or Metastatic GC and GCJ Adenocarcinoma
Sponsor: Women's College Hospital. Phase: . Conditions: Sleep Disorder, Sleep Disturbance
Sponsor: University of Michigan Rogel Cancer Center. Phase: NA. Conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Sponsor: Aurion Biotech. Phase: PHASE3. Conditions: Corneal Edema, Corneal Endothelial Dysfunction, Fuchs Endothelial Corneal Dysfunction, Pseudophakic Bullous Keratopathy (PBK)
Sponsor: Wroclaw Medical University. Phase: . Conditions: Temporomandibular Disorders (TMD), Muscle Pain, TMJ Pain
Sponsor: CSL Behring. Phase: PHASE3. Conditions: Hereditary Angioedema
Sponsor: Fu Jen Catholic University. Phase: . Conditions: Biomarkers, Lung Adenocarcinoma, Pleural Effusion
Sponsor: Cancer Trials Ireland. Phase: PHASE1. Conditions: HER2 Positive Breast Cancer
Sponsor: French Africa Pediatric Oncology Group. Phase: . Conditions: Staging, Therapeutic Recommendations
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Phase: . Conditions: Hair Loss
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.. Phase: PHASE3. Conditions: Refractory Metastatic Colorectal Cancer
Sponsor: University of Louisville. Phase: NA. Conditions: Spinal Cord Injuries
Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Pancreatic Acinar Cell Carcinoma
Sponsor: Eli Lilly and Company. Phase: PHASE1. Conditions: Healthy
Sponsor: Peking University People's Hospital. Phase: NA. Conditions: Endometrium Cancer
Sponsor: University of Alabama at Birmingham. Phase: PHASE2. Conditions: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild. Phase: PHASE2. Conditions: Chemical Burns, Ocular Burns
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma
Sponsor: Sequenom, Inc.. Phase: . Conditions: Preeclampsia (PE)
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Zollinger Ellison Syndrome
Sponsor: SWOG Cancer Research Network. Phase: PHASE3. Conditions: Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8